Loading...
•
Dec 31, 2025
Pennant Group Q4 2025 Earnings Report
Pennant Group reported record-breaking performance and growth for the fourth quarter and fiscal year 2025.
Key Takeaways
Pennant Group achieved significant growth in Q4 2025, with revenue increasing 53.2% year-over-year to $289.3 million. The company saw strong momentum in its Home Health and Hospice segment, driven by strategic acquisitions and organic growth, while the Senior Living segment showed steady improvement in occupancy and rates.
Total revenue for Q4 increased by 53.2% to $289.3 million compared to the prior year quarter.
Home Health admissions surged by 81.3% and Medicare Home Health admissions grew by 87.5% in Q4.
Hospice average daily census increased by 46.9% to 5,060 in the fourth quarter.
Senior Living occupancy improved by 200 basis points to 80.6% with a 5.6% increase in revenue per occupied unit.
Revenue by Segment
Forward Guidance
Management provided 2026 annual guidance reflecting continued growth and the integration of assets from UnitedHealth and Amedisys.
Positive Outlook
- Anticipated total revenue between $1.13 billion and $1.17 billion.
- Adjusted earnings per diluted share expected between $1.26 and $1.36.
- Adjusted EBITDA projected between $88.5 million and $94.1 million.
- Expected revenue of $191.2 to $200.3 million from former UnitedHealth and Amedisys assets.
- Operational flywheel gaining momentum with strategic expansion in the Southeast.
Challenges Ahead
- Guidance includes certain costs relating to the transition services agreement with UnitedHealth.
- Includes impacts of reimbursement rate adjustments.
- Excludes potential unannounced acquisitions.
- Excludes net income attributable to noncontrolling interest.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...